Evidence map›Paper›PMID 32138287›Full record

ReviewJournal of clinical medicine2020

Early Aspirin Discontinuation Following Acute Coronary Syndrome or Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.

Paul Guedeney, Jules Mesnier, Sabato Sorrentino, Farouk Abcha, Michel Zeitouni, Benoit Lattuca, Johanne Silvain, Salvatore De Rosa, Ciro Indolfi, Jean-Philippe Collet and 2 more

Open access · goldAbstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Journal of clinical medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Paul GuedeneySorbonne university, ACTION Study Group, INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière hospital (AP-HP) Paris, 75013 Paris, France.
Jules MesnierSorbonne university, ACTION Study Group, INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière hospital (AP-HP) Paris, 75013 Paris, France.
Sabato SorrentinoDivision of Cardiology, Department of Medical and Surgical Science, Magna Graecia University, 88100 Catanzaro, Italy.
Farouk AbchaSorbonne university, ACTION Study Group, INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière hospital (AP-HP) Paris, 75013 Paris, France.
Michel ZeitouniSorbonne university, ACTION Study Group, INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière hospital (AP-HP) Paris, 75013 Paris, France.
Benoit LattucaSorbonne university, ACTION Study Group, INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière hospital (AP-HP) Paris, 75013 Paris, France.
Johanne SilvainSorbonne university, ACTION Study Group, INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière hospital (AP-HP) Paris, 75013 Paris, France.
Salvatore De RosaDivision of Cardiology, Department of Medical and Surgical Science, Magna Graecia University, 88100 Catanzaro, Italy.ORCID 0000-0001-5388-942X
Ciro IndolfiDivision of Cardiology, Department of Medical and Surgical Science, Magna Graecia University, 88100 Catanzaro, Italy.ORCID 0000-0003-1241-6487
Jean-Philippe ColletSorbonne university, ACTION Study Group, INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière hospital (AP-HP) Paris, 75013 Paris, France.
Mathieu KerneisSorbonne university, ACTION Study Group, INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière hospital (AP-HP) Paris, 75013 Paris, France.
Gilles MontalescotSorbonne university, ACTION Study Group, INSERM UMRS_1166, Cardiology Institute, Pitié Salpêtrière hospital (AP-HP) Paris, 75013 Paris, France.
Inserm · FRMagna Graecia University · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The respective ischemic and bleeding risks of early aspirin discontinuation following an acute coronary syndrome (ACS) or percutaneous coronary intervention (PCI) remain uncertain. We performed a prospero-registered review of randomized controlled trials (RCTs) comparing a P2Y

Indexed as

acute coronary syndromeantiplatelet therapyaspirinP2Y12 inhibitorspercutaneous coronary intervention

Identifiers

PMID32138287
PMCPMC7141190
OpenAlexW3010079927

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.